[Webinar] Perspectives from U.S. Clinical Settings : Retinal AI in Cardiovascular Care
We’re pleased to welcome Dr. Manessis, an Endocrinology & Metabolism Specialist, who will share perspectives from his hospital and discuss his team’s experience evaluating Dr. Noon CVD and exploring how it may fit within existing clinical workflows.
*Dr. Noon CVD is an investigational software not yet FDA-cleared, currently available for research and evaluation as part of its U.S. launch preparation.
Date : 19 March 2026
Time : 6:00AM (PT) l 9:00AM (ET)
About Speaker
Anastasios Manessis
MD, FACE, ECNU, ABOM
Anastasios Manessis, MD, FACE, ECNU, ABOM, is a double-board certified physician at Endocrine Associates of West Village PC in Murray Hill, Manhattan, and Long Island City, New York, specializing in endocrinology, diabetes, and metabolism and obesity medicine. Dr. Manessis has an endocrine certification in neck ultrasounds and has extensive experience in diagnosing, treating, and managing endocrine disorders, including diabetes, thyroid disorders, hormonal dysfunction, and obesity.
Dr. Manessis pursued his undergraduate education at Manhattan College, graduating magna cum laude with distinction in biochemistry. He earned his medical degree from the State University of New York at Buffalo. Dr. Manessis completed a combined residency in internal medicine and pediatrics at New York Medical College at Saint Vincent’s Hospital in New York. Following a year as chief medical resident, he completed a two-year clinical fellowship in endocrinology, diabetes, and metabolism, where his research interest, among others, involved the use of insulin pumps in patients with Type II diabetes.
In addition to his clinical practice, Dr. Manessis was a faculty member in the Department of Medicine at New York Medical College from 2008-2010. He then joined the faculty of New York University in 2011. He has been involved in many clinical research projects, including long-term studies to evaluate the efficacy and safety of GLP-I agonists and weight loss agents. Dr. Manessis’ primary clinical interest includes the treatment of diabetic patients with insulin pumps and how it has benefited the well-being of patients long-term.